Alfresa Holdings Corporation logo

Alfresa Holdings Corporation (2784)

Market Closed
7 Aug, 06:00
JPX JPX
¥
2,200. 00
+2.5
+0.1138%
¥
429.4B Market Cap
- P/E Ratio
0.22% Div Yield
565,700 Volume
- Eps
¥ 2,197.5
Previous Close
Add Transaction
Day Range
2,172.5 2,215
Year Range
2,055 2,685.5
Want to track 2784 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

2784 closed Friday higher at ¥2,200, an increase of 0.1138% from Thursday's close, completing a monthly increase of 1.196% or ¥26. Over the past 12 months, 2784 stock lost -9.9652%.
2784 pays dividends to its shareholders, with the most recent payment made on Dec 01, 2025. The next announced payment will be in In 1 month on Sep 29, 2026 for a total of ¥35.
The last earnings report, released on May 13, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Alfresa Holdings Corporation has completed 1 stock splits, with the recent split occurring on Sep 26, 2014.
The company's stock is traded on one exchange.

2784 Chart

People also search for

Japan Tobacco Inc.
¥ 7,095
-0.1829%
Kao Corporation
¥ 3,738
+2.2989%
Pan Pacific International Holdings Corporation
¥ 926.4
+0.948%
Suntory Beverage & Food Ltd.
¥ 4,639
-0.2366%
Toyo Suisan Kaisha Ltd.
¥ 10,590
-0.9355%

Alfresa Holdings Corporation (2784) FAQ

What is the stock price today?

The current price is ¥2,200.00.

On which exchange is it traded?

Alfresa Holdings Corporation is listed on JPX.

What is its stock symbol?

The ticker symbol is 2784.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.22%.

What is its market cap?

As of today, the market cap is 429.4B.

Has Alfresa Holdings Corporation ever had a stock split?

Alfresa Holdings Corporation had 1 splits and the recent split was on Sep 26, 2014.

Alfresa Holdings Corporation Profile

Consumer Staples Distribution & Retail Industry
Consumer Staples Sector
Ryuji Arakawa CEO
JPX Exchange
JP3126340003 ISIN
JP Country
12,525 Employees
29 Sep 2026 Last Dividend
26 Sep 2014 Last Split
- IPO Date

Overview

Alfresa Holdings Corporation is a prominent player in the pharmaceutical and medical device industry, with a broad spectrum of activities that span the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment. The company boasts an international presence, extending its vast array of services and products beyond the domestic market of Japan. Founded in 2003 and headquartered in Tokyo, Japan, Alfresa has strategically positioned itself in the healthcare sector by catering to a wide range of needs, from hospitals and clinics to drug stores and pharmacies. Through its extensive network of subsidiaries, Alfresa Holdings Corporation is dedicated to improving healthcare quality and accessibility by leveraging its deep industry knowledge and expansive product portfolio.

Products and Services

  • Ethical Pharmaceuticals Wholesaling
  • Alfresa plays a crucial role in the wholesale distribution of ethical pharmaceuticals, offering an extensive range of diagnostic reagents and medical devices/equipment. This segment primarily serves hospitals, clinics, and dispensing pharmacies, ensuring that healthcare providers have access to essential medical products for patient care.

  • Self-Medication Products Wholesaling
  • In this domain, Alfresa provides a wide array of over-the-counter drugs, health foods, supplements, and additional products. Targeting drug stores and pharmacies, the company supports the self-care practices of consumers by supplying quality self-medication products.

  • Manufacture and Marketing of Pharmaceuticals and Medical Devices
  • Alfresa not only markets but also engages in the manufacturing of active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices. This comprehensive involvement in the product lifecycle enables the company to ensure the highest quality standards and innovations in healthcare products.

  • Contract Manufacturing of Pharmaceuticals
  • The company extends its manufacturing prowess to other entities through contract manufacturing services. This allows Alfresa to collaborate with various partners in the healthcare industry, facilitating the production of pharmaceuticals under contracted terms.

  • Medical-Related Business
  • Beyond products, Alfresa Holdings Corporation operates a dispensing pharmacy business along with other medical-related ventures. This diversification ensures that the company can meet a broad spectrum of healthcare needs, contributing to the well-being of communities it serves.

Contact Information

Address: 1-1-3 Otemachi
Phone: 81 3 5219 5100